3D Medicines Inc

01244

Company Profile

  • Business description

    3D Medicines Inc is a commercial-stage biopharmaceutical company engaged in the research and development of oncology therapies for cancer patients, especially those who require long-term care. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life. It generates all of its revenue from China.

  • Contact

    No. 3 and No. 5, Laiyang Road
    Shandong
    Qingdao
    CHN

    https://www.3d-medicines.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    183

Stocks News & Analysis

stocks

Microsoft earnings: Strong, including Azure, but overall guidance is in line

We think Microsoft stock is moderately undervalued.
stocks

After earnings, is Tesla stock a buy, a sell, or fairly valued?

Q3 earnings reflected sequential improvement driven by record auto deliveries and energy storage deployments.
stocks

3 cheap fully franked stocks

Well priced Aussie shares that offer a tax rebate.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,230.1023.400.25%
CAC 408,157.2943.59-0.53%
DAX 4024,118.895.32-0.02%
Dow JONES (US)47,522.12109.88-0.23%
FTSE 1009,760.063.920.04%
HKSE26,282.6963.45-0.24%
NASDAQ23,581.14377.33-1.57%
Nikkei 22552,199.36873.751.70%
NZX 50 Index13,529.2869.990.52%
S&P 5006,822.3468.25-0.99%
S&P/ASX 2008,933.2020.000.22%
SSE Composite Index3,986.860.04-0.00%

Market Movers